UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma

British journal of cancer, 2017-10, Vol.117 (9), p.1295-1302

2017

Volltextzugriff (PDF)

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence

Nature communications, 2021-09, Vol.12 (1), p.5507-5507, Article 5507

2021

Volltextzugriff (PDF)

Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies

British journal of cancer, 2016-01, Vol.114 (1), p.7-13

2016

Volltextzugriff (PDF)

Frequency of leukemic initiating cells does not depend on the xenotransplantation model used

Leukemia, 2012-04, Vol.26 (4), p.858-860

2012

Volltextzugriff (PDF)

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.824-830

2012

Volltextzugriff (PDF)

Thalidomide in multiple myeloma: Current status and future prospects

British journal of haematology, 2003-01, Vol.120 (1), p.18-26

2003

Volltextzugriff (PDF)

Nosocomial transmission of parainfluenza 3 virus in hematological patients characterized by molecular epidemiology

Transplant infectious disease, 2011-08, Vol.13 (4), p.433-437

2011

Volltextzugriff (PDF)

An UK myeloma forum phase II study of thalidomide; long term follow-up and recommendations for treatment

Leukemia research, 2003-10, Vol.27 (10), p.909-914

2003

Volltextzugriff (PDF)

Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care

Anaesthesia, 2005-04, Vol.60 (4), p.340-347

2005

Volltextzugriff (PDF)

Durable Remissions of Myelodysplastic Syndrome and Acute Myeloid Leukemia After Reduced-Intensity Allografting

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3060-3065

2003

Volltextzugriff (PDF)

Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia

Journal of clinical pathology, 2005-09, Vol.58 (9), p.994-995

2005

Volltextzugriff (PDF)

Hepatitis‐associated aplastic anaemia treated successfully with antilymphocyte globulin

Clinical and laboratory haematology, 2005-10, Vol.27 (5), p.331-333

2005

Volltextzugriff (PDF)

PAD combination therapy (PS‐341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma

British journal of haematology, 2005-06, Vol.129 (6), p.755-762

2005

Volltextzugriff (PDF)

PF642 REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS A SAFE AND EFFECTIVE TREATMENT OPTION IN HIGH RISK MYELOMA PATIENTS – A SINGLE CENTRE EXPERIENCE

HemaSphere, 2019-06, Vol.3 (S1), p.274-n/a

2019

Volltextzugriff (PDF)

Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: Impact on stem cell harvesting and engraftment

Leukemia & lymphoma, 2007-01, Vol.48 (10), p.1910-1921

2007

Volltextzugriff (PDF)

A forgotten cause of abdominal pain

Journal of the Royal Army Medical Corps, 1998-02, Vol.144 (1), p.29-30

1998

Volltextzugriff (PDF)

CASE REPORT: Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin

Clinical and laboratory haematology, 2005-10, Vol.27 (5), p.331-333

2005

Volltextzugriff (PDF)

PAD therapy (bortezomib, doxorubicin and dexamethasone) for untreated multiple myeloma (MM)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6550-6550

2004

Volltextzugriff (PDF)

PAD therapy (bortezomib, doxorubicin and dexamethasone) for untreated multiple myeloma (MM)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6550-6550

2004

Volltextzugriff (PDF)

A236 Second Autologous Transplantation After Bortezomib-Based Re-Induction Therapy: The UK Experience

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S40-S41

2009

Volltextzugriff (PDF)

A161 The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma: An Update

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S27-S27

2009

Volltextzugriff (PDF)

Myeloma

Hematology (Luxembourg), 2002-01, Vol.7 (6), p.371-371

Oakervee, Dr H.

2002

Volltextzugriff (PDF)

Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin

Clinical & Laboratory Haematology, 2005, Vol.27 (5), p.331-333

2005

Volltextzugriff (PDF)

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Annals of hematology, 2019-09, Vol.98 (9), p.2139-2150

2019

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Humans
(15)
Oncology
(10)
Adult
(9)
Biological And Medical Sciences
(9)
Female
(9)
Hematology
(9)
Male
(9)
Medical Sciences
(9)
Middle Aged
(9)
Multiple Myeloma
(7)
Aged
(6)
Multiple Myeloma - Drug Therapy
(5)
Cancer Research
(4)
Chemotherapy
(4)
Medicine
(4)
Medicine & Public Health
(4)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(3)
Animals
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence

Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies

Frequency of leukemic initiating cells does not depend on the xenotransplantation model used

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

Thalidomide in multiple myeloma: Current status and future prospects

Nosocomial transmission of parainfluenza 3 virus in hematological patients characterized by molecular epidemiology

An UK myeloma forum phase II study of thalidomide; long term follow-up and recommendations for treatment

Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care

Durable Remissions of Myelodysplastic Syndrome and Acute Myeloid Leukemia After Reduced-Intensity Allografting

Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia

Hepatitis‐associated aplastic anaemia treated successfully with antilymphocyte globulin

PAD combination therapy (PS‐341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma

PF642 REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS A SAFE AND EFFECTIVE TREATMENT OPTION IN HIGH RISK MYELOMA PATIENTS – A SINGLE CENTRE EXPERIENCE

Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: Impact on stem cell harvesting and engraftment

Randomized Phase III Study (ADMYRE) of Plitidepsin in Combination with Dexamethasone Vs. Dexamethasone Alone in Patients with Relapsed/Refractory Multiple Myeloma

A forgotten cause of abdominal pain

CASE REPORT: Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin

PAD therapy (bortezomib, doxorubicin and dexamethasone) for untreated multiple myeloma (MM)

PAD therapy (bortezomib, doxorubicin and dexamethasone) for untreated multiple myeloma (MM)

A236 Second Autologous Transplantation After Bortezomib-Based Re-Induction Therapy: The UK Experience

A161 The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma: An Update

Myeloma

Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Suchergebnisse filtern